Scinai Immunotherapeutics (SCNI) Profit After Tax Growth (1y) (2015 - 2024)
Scinai Immunotherapeutics (SCNI) Profit After Tax Growth (1y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 66.06% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 17.05% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -129.68% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -290.15% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -632.44% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 59.59% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.88% |
| Sep 30, 2024 | 452.56% |
| Jun 30, 2024 | -38.28% |
| Mar 31, 2024 | -38.58% |
| Dec 31, 2023 | 54.46% |
| Sep 30, 2023 | 34.97% |
| Jun 30, 2023 | 78,635.87% |
| Mar 31, 2023 | 242.02% |
| Dec 31, 2022 | -124.34% |
| Sep 30, 2022 | 47.18% |
| Jun 30, 2022 | 100.04% |
| Mar 31, 2022 | -0.77% |
| Dec 31, 2021 | 249.10% |
| Sep 30, 2021 | -116.35% |
| Mar 31, 2021 | 33.53% |
| Sep 30, 2020 | 385.79% |
| Mar 31, 2020 | -752.83% |
| Sep 30, 2019 | -2,709.14% |
| Jun 30, 2019 | -100.41% |
| Mar 31, 2019 | 114.01% |